← FDA DRUG APPROVALS

FDA ANDA · ANDA201276

CIDOFOVIR

cidofovir anhydrous

Sponsor: MYLAN INSTITUTIONAL

APPLICATION
ANDA201276
TYPE
ANDA
ORIGINAL APPROVAL
2012-06-27
LATEST ACTION
2012-06-27
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

CIDOFOVIRPrescription
CIDOFOVIR EQ 375MG BASE/5ML (EQ 75MG BASE/ML) · SOLUTION · INTRAVENOUS

Approval history

2012-06-27OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →